Cherry Blossom IBD Education Meeting 2024 Á¦ 9ȸ °æÈñ´ëÇб³º´¿ø ¿°Áõ¼ºÀåÁúȯ ¿¬¼ö°Á : 2024-03-10
±³À°ÀÏÀÚ : 2024-03-10
±³À°Àå¼Ò : °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç
±³À°ÁÖÁ¦ : Cherry Blossom IBD Education Meeting 2024 Á¦ 9ȸ °æÈñ´ëÇб³º´¿ø ¿°Áõ¼ºÀåÁúȯ ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : °æÈñ´ëÇб³º´¿ø
´ã´çÀÚ : Á¶¹Ì¿µ
¿¬¶ôó : 02-958-8199
À̸ÞÀÏ : kmcim@naver.com
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 08:30~08:50 Assessment of IBD Scores and Indices: How I Do It? ³ª¼ö¿µ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 08:50~09:10 Obesity and Metabolic Disorders in IBD ¹Ú¿¹Çö(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 09:10~09:30 Case-Based Learning of Intestinal Ultrasound ¿À½ÅÁÖ(°æÈñÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 09:30~09:50 Integrating Artificial Intelligence and ChatGPT in IBD Management Ȳ¼º¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 10:05~10:25 Meticulous Mastery: Corticosteroids and Thiopurines in IBD Care ½ÅÁ¤Àº(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 10:25~10:45 Loss of Response: Optimization vs. Swapping °»ó¹ü(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 10:45~11:05 Positioning of New Small Molecules within our IBD Armamentarium ÀÌÁØ(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 11:05~11:30 Special lecture - FMT and Beyond: Microbiome-based Therapies in IBD °íÈ«(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 11:45~12:10 Revisiting CT in IBD Assessment ¹®¼º°æ(°æÈñÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 12:10~12:35 Emergent IBD Cases We Should Know ¹Ú»óÇü(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 10ÀÏ °æÈñ´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ1Ãþ Á¦1¼¼¹Ì³ª½Ç 12:35~13:00 Dual Dilemmas: Optimizing IBD Therapy in Malignant Scenarios ±èÀº¼ö(°æºÏÀÇ´ë)